Use of dha as a pharmaceutical composition

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 31/20 (2006.01) A61K 31/202 (2006.01)

Patent

CA 2195979

A method of combating dyslexia, or inadequate night vision or dark adaptation in dyslexics or normal persons, and a method of manufacture of a medicament for such purposes, characterised by administering/incorporating DHA as an active in effective amount, optionally in association with other n-3 essential fatty acids and n-6 essential fatty acids.

Cette invention concerne un procédé de lutte contre la dyslexie ou contre l'insuffisance de la vision nocturne ou de l'adaptation à l'obscurité chez des personnes saines ou atteintes de dyslexie. Cette invention concerne également un procédé de fabrication d'un médicament adapté à ce type de traitement qui consiste à incorporer à ce médicament, qui sera ensuite administré à une personne, une quantité efficace d'acide docosahexanoïque (DHA) en tant que produit actif, éventuellement en association avec des acides gras essentiels n-3 et des acides gras essentiels n-6.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Use of dha as a pharmaceutical composition does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Use of dha as a pharmaceutical composition, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of dha as a pharmaceutical composition will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-2022315

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.